Allmed Medical Products Co Ltd
SZSE:002950
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
CN |
A
|
Allmed Medical Products Co Ltd
SZSE:002950
|
5.2B CNY | 67.5 | |
CH |
Alcon AG
SIX:ALC
|
40.4B CHF | 42.1 | ||
JP |
Hoya Corp
TSE:7741
|
6.5T JPY | 38.8 | ||
DK |
Coloplast A/S
CSE:COLO B
|
191.2B DKK | 38.5 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19.3B USD | 41.9 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 64.8 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
57.9B CNY | 33.6 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 50.1 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.7B USD | -60.1 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF | 72.1 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 12 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.